Xylem 10-Q 2026-09-30
XYL · CIK 1524472 · Form 10-Q · Period ended September 30, 2026 · Filed October 27, 2026
Revenue fell 3.0% to $2.20 billion. Operating margin was 17.5%, against 14.7% a year earlier. Net income was $291 million.
8 sections, 297K characters. Original on sec.gov · ·
| Measure | Quarter ended Sep 30, 2026 | Quarter ended Sep 30, 2025 | Change |
|---|---|---|---|
| Revenue | $2.20B | $2.27B | -3.0% |
| Operating income | $385M | $334M | +15.3% |
| Net income | $291M | $227M | +28.2% |
| Diluted EPS | $1.25 | $0.93 | +34.4% |
| Cash and equivalents | $708M | n/a | n/a |
| Operating margin* | 17.5% | 14.7% | +2.8 pts |
From the XBRL facts tagged to this filing; both columns are as reported in this filing. * Computed by filings.tools: free cash flow is operating cash flow less capital spending; operating margin is operating income over revenue.
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||||||||
| For the quarterly period ended | September 30, 2026 | |||||||||||||
| or | ||||||||||||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 1-35229
Xylem Inc.
(Exact name of registrant as specified in its charter)
| Indiana | 45-2080495 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
301 Water Street SE, Washington, DC 20003
(Address of principal executive offices and zip code)
(202) 869-9150
(Registrant's telephone number, including area code)
| Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $0.01 per share | XYL | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer | ☑ | Accelerated filer | ☐ | |||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of October 23, 2026, there were 229,334,592 outstanding shares of the registrant's common stock, par value $0.01 per share.
Xylem Inc.
Table of Contents
PART I
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
| Three Months | Nine Months | ||||||||||||||||||||||||||||
| For the periods ended September 30, | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| Revenue from products | $ | 1,807 | $ | 1,867 | $ | 5,517 | $ | 5,487 | |||||||||||||||||||||
| Revenue from services | 394 | 401 | 1,145 | 1,151 | |||||||||||||||||||||||||
| Revenue | 2,201 | 2,268 | 6,662 | 6,638 | |||||||||||||||||||||||||
| Cost of revenue from products | 1,026 | 1,109 | 3,176 | 3,279 | |||||||||||||||||||||||||
| Cost of revenue from services | 268 | 276 | 813 | 816 | |||||||||||||||||||||||||
| Cost of revenue | 1,294 | 1,385 | 3,989 | 4,095 | |||||||||||||||||||||||||
| Gross profit | 907 | 883 | 2,673 | 2,543 | |||||||||||||||||||||||||
| Selling, general and administrative expenses | 458 | 474 | 1,433 | 1,437 | |||||||||||||||||||||||||
| Research and development expenses | 56 | 52 | 171 | 166 | |||||||||||||||||||||||||
| Restructuring and asset impairment charges | 8 | 23 | 50 | 70 | |||||||||||||||||||||||||
| Operating income | 385 | 334 | 1,019 | 870 | |||||||||||||||||||||||||
| Interest expense | (21) | (6) | (32) | (23) | |||||||||||||||||||||||||
| Other non-operating income, net | 6 | 6 | 3 | 13 | |||||||||||||||||||||||||
| Loss on sale of businesses | (5) | (37) | (17) | (47) | |||||||||||||||||||||||||
| Income before taxes | 365 | 297 | 973 | 813 | |||||||||||||||||||||||||
| Income tax expense | (77) | (71) | (235) | (196) | |||||||||||||||||||||||||
| Net income | $ | 288 | $ | 226 | $ | 738 | $ | 617 | |||||||||||||||||||||
| Net loss attributable to non-controlling interests | 3 | 1 | 9 | 5 | |||||||||||||||||||||||||
| Net income attributable to Xylem | $ | 291 | $ | 227 | $ | 747 | $ | 622 | |||||||||||||||||||||
| Earnings per share: | |||||||||||||||||||||||||||||
| Basic | $ | 1.25 | $ | 0.93 | $ | 3.15 | $ | 2.56 | |||||||||||||||||||||
| Diluted | $ | 1.25 | $ | 0.93 | $ | 3.14 | $ | 2.55 | |||||||||||||||||||||
| Weighted average number of shares: | |||||||||||||||||||||||||||||
| Basic | 232.7 | 243.5 | 237.3 | 243.3 | |||||||||||||||||||||||||
| Diluted | 233.0 | 244.1 | 237.7 | 243.9 | |||||||||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(in millions)
| Three Months | Nine Months | ||||||||||||||||||||||||||||
| For the periods ended September 30, | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| Net income | $ | 288 | $ | 226 | $ | 738 | $ | 617 | |||||||||||||||||||||
| Other comprehensive income (loss), before tax: | |||||||||||||||||||||||||||||
| Foreign currency translation adjustment | (24) | (6) | (71) | 87 | |||||||||||||||||||||||||
| Amount of currency translation adjustment relating to divestiture of foreign subsidiaries reclassified into net income | 7 | — | (1) | 8 | |||||||||||||||||||||||||
| Net change in derivative hedge agreements: | |||||||||||||||||||||||||||||
| Unrealized (loss) gain | (2) | 1 | (14) | 31 | |||||||||||||||||||||||||
| Amount of loss (gain) reclassified into net income | 2 | (5) | (4) | (2) | |||||||||||||||||||||||||
| Net change in post-retirement benefit plans: | |||||||||||||||||||||||||||||
| Amortization of net actuarial gain into net income | — | — | — | 1 | |||||||||||||||||||||||||
| Foreign currency translation adjustment | 1 | 1 | 3 | (2) | |||||||||||||||||||||||||
| Amount of gain recognized relating to divestiture of foreign subsidiaries reclassified into net income | — | — | (3) | — | |||||||||||||||||||||||||
| Other comprehensive (loss) income, before tax | (16) | (9) | (90) | 123 | |||||||||||||||||||||||||
| Income tax (benefit) expense related to items of other comprehensive income | (11) | 2 | 7 | (79) | |||||||||||||||||||||||||
| Other comprehensive (loss) income, net of tax | (5) | (11) | (97) | 202 | |||||||||||||||||||||||||
| Comprehensive income | $ | 283 | $ | 215 | $ | 641 | $ | 819 | |||||||||||||||||||||
| Comprehensive loss attributable to non-controllin |
Showing the first 8K of 169K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the condensed consolidated financial statements, including the notes, included elsewhere in this report on Form 10-Q (this "Report").
This Report contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” "goal," "objective," “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessarily to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector demand and spending, interest rates, availability of funding to our customers, timing of our customers' capital spending and project deployments, inflation and governments' related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for, and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth and portfolio optimization actions, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; our level of indebtedness, including debt incurred to finance the pending Cornell Pump and Roper Pump acquisition, difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 (" 2025 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Overview
Xylem is a leading global water technology company. We design, manufacture and service highly engineered products and solutions ranging across a wide variety of critical applications in utility, industrial, residential and commercial building services settings. Our broad portfolio of solutions addresses customer needs across the water cycle, from the delivery, measurement and use of drinking water to the collection, test, treatment and analysis of wastewater, to the return of water to the environment. Our product and service offerings are organized into four reportable segments that are aligned around the critical market applications they provide: Water Infrastructure, Applied Water, Measurement and Control Solutions and Water Solutions and Services.
-
Water Infrastructure serves the water infrastructure sector with pump systems that transport water from aquifers, lakes, rivers and seas; with filtration, ultraviolet and ozone systems that provide treatment, making the water fit to use; and pumping solutions that move the wastewater and storm water to treatment facilities where our mixers, biological treatment, monitoring and control systems provide the primary functions in the treatment process.
-
Applied Water serves the water usage applications sector with water pressure boosting systems for heating, ventilation and air conditioning, and for fire protection systems to the residential and commercial building solutions markets.
-
Measurement and Control Solutions primarily serves the utility infrastructure solutions and services sector by delivering communications, smart metering, measurement and control capabilities and critical infrastructure technologies that allow customers to more effectively use their distribution networks for the delivery, monitoring and control of critical resources such as water, electricity and natural gas. We also provide analytical instrumentation used to measure and analyze water quality, flow and level in clean water, wastewater and outdoor water environments.
-
Water Solutions and Services provides tailored services and solutions, in collaboration with customers, including on‑demand water, outsourced water, recycle/reuse, pipeline assessment services, specialty dewatering and emergency response service alternatives to improve operational reliability, performance and environmental compliance.
Executive Summary
Xylem reported revenue for the third quarter of 2026 of $2,201 million, a decrease of 3.0% compared to $2,268 million reported in the third quarter of 2025. The revenue
Showing the first 8K of 109K characters. Open the full section
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There has been no material change in the information concerning market risk as stated in our 2025 Annual Report.
Item 4. CONTROLS AND PROCEDURES
Our management, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, has evaluated the effectiveness of our disclosure controls and procedures (as defined in rules 13a- 15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were effective at the reasonable assurance level.
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the 1934 Act) during the fiscal quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are involved in legal and regulatory proceedings that are incidental to the operation of our businesses (or the business operations of previously owned entities). These proceedings may seek remedies relating to matters including environmental, tax, intellectual property, acquisitions or divestitures, product liability, property damage, personal injury, privacy, employment, labor and pension, government investigations or contract issues and commercial or contractual disputes.
See Note 18, "Commitments and Contingencies" to the condensed consolidated financial statements for further information and any updates.
Item 1A. RISK FACTORS
There have been no material changes from the risk factors previously disclosed in "Item 1A. Risk Factors" of our 2025 Annual Report.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table presents information with respect to purchases of the Company's common stock by the Company during the three months ended September 30, 2026:
| PERIOD | TOTAL NUMBER OF SHARES PURCHASED | AVERAGE PRICE PAID PER SHARE (a) | TOTAL NUMBER OF SHARES PURCHASED AS PART OF PUBLICLY ANNOUNCED PLANS OR PROGRAMS (b)(c) | APPROXIMATE DOLLAR VALUE OF SHARES THAT MAY YET BE PURCHASED UNDER THE PLANS OR PROGRAMS (b) (IN MILLIONS) | ||||||||||||||||||||||
| 7/1/26 - 7/30/26 | 70,114 | $117.12 | 70,071 | $445 | ||||||||||||||||||||||
| 8/1/26 - 8/31/26 | 1,117,901 | $114.50 | 1,117,901 | $317 | ||||||||||||||||||||||
| 9/1/26 - 9/30/26 | 1,982,331 | $107.14 | 1,980,000 | $105 | ||||||||||||||||||||||
| Total | 3,170,346 | $109.95 | 3,167,972 |
(a)Average price paid per share is calculated on a settlement basis.
(b)On February 25, 2026, our Board of Directors authorized the repurchase of up to $1.5 billion in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our stockholders and maintains our focus on growth. Repurchases made under the program can be effected through open market transactions, block purchases, accelerated share repurchase agreements or other negotiated transactions.
(c)Amounts presented are exclusive of the excise tax on share repurchases
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
Item 5. OTHER INFORMATION
(c) Trading Plans
During the quarter ended September 30, 2026, no director or Section 16 officer adopted or terminated any Rule 10b5-1 Plan or non-Rule 10b5-1 Plan arrangements (in each case, as defined in Item 408(a) of Regulation S-K).
Item 6. EXHIBITS
See the Exhibit Index for a list of exhibits filed as part of this report and incorporated herein by reference.
XYLEM INC.
EXHIBIT INDEX
| Exhibit Number | Description | Location | |||||||||||||||
| 3.1 | Fourth Amended and Restated Articles of Incorporation of Xylem Inc. | Incorporated by reference to Exhibit 3.1 of Xylem Inc.’s Form 8-K filed on May 15, 2017 (CIK No. 1524472, File No. 1-35229). | |||||||||||||||
| 3.2 | Fifth Amended and Restated By-laws of Xylem Inc. | Incorporated by reference to Exhibit 3.1 of Xylem Inc.’s Form 8-K filed on November 15, 2022 (CIK No. 1524472, File No. 1-35229). | |||||||||||||||
| 4.1 | Sixth Supplemental Indenture, dated September 29, 2026, by and between the Company and Deutsche Bank Trust Company Americas, as trustee | Incorporated by reference to Exhibit 4.1 of Xylem Inc.'s Form 8-K filed September 29, 2026 (CIK No. 1524472, File No. 1-35229) | |||||||||||||||
| 4.2 | Form of 5.250% Senior Notes due 2029 | Incorporated by reference to Exhibit 4.1 of Xylem Inc.'s Form 8-K filed on September 29, 2026 (CIK No. 1524472, File No. 1-35229) | |||||||||||||||
| 4.3 | Form of 5.450% Senior Notes due 2032 | Incorporated by reference to Exhibit 4.1 of Xylem Inc.'s Form 8-K filed on September 29, 2026 (CIK No. 1524472, File No. 1-35229) | |||||||||||||||
| 4.4 | Form of 5.850% Senior Notes due 2037 | Incorporated by reference to Exhibit 4.1 of Xylem Inc.'s Form 8-K filed on September 29, 2026 (CIK No. 1524472, File No. 1-35229) | |||||||||||||||
| 10.1 | Five-Year Revolving Credit Facility Agreement, dated as of September 8, 2026 among Xylem Inc. and the Lenders party thereto. | Incorporated by reference to Exhibit 10.1 of Xylem Inc.'s Form 8-K filed on September 8, 2026 (CIK No. 1524472, File No. 1-35229) | |||||||||||||||
| 10.2 | Letter Agreement between Xylem Inc. and Andrea van der Berg | Filed herewith. | |||||||||||||||
| 31.1 | Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | |||||||||||||||
| 31.2 | Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | |||||||||||||||
| 32.1 | Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b) (32) (ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference. | |||||||||||||||
| 101.0 | The following materials from Xylem Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) Condensed Consolidated Income Statements, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows and (v) Notes to Condensed Consolidated Financial Statements | The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. | |||||||||||||||
| 104.0 | The cover page from Xylem Inc.'s Quarterly Report on Form 10-Q for the period ended September 30, 2026 formatted in Inline XBRL and contained in Exhibit 101.0. | ||||||||||||||||
| # Management contract or compensatory plan or arrangement |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| XYLEM INC. | |||||
| (Registrant) | |||||
| /s/ Geri-Michelle McShane | |||||
| Geri-Michelle McShane | |||||
| Senior Vice President, Chief Accounting Officer |
October 27, 2026